Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Net Margin (2024 - 2025)

Historic Net Margin for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 49.48%.

  • Day One Biopharmaceuticals' Net Margin fell 877100.0% to 49.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 113.48%, marking a year-over-year increase of 762700.0%. This contributed to the annual value of 156.08% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Net Margin is 49.48%, which was down 877100.0% from 89.37% recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' Net Margin peaked at 38.22% during Q3 2024, and registered a low of 1372.03% during Q2 2024.